Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1994 Sep;62(9):3844–3849. doi: 10.1128/iai.62.9.3844-3849.1994

Effect of lipopolysaccharide on mouse mast cell induction by a splenic cell culture system.

Z Q Hu 1, K Asano 1, T Yamazaki 1, T Shimamura 1
PMCID: PMC303039  PMID: 7520422

Abstract

We have previously reported a method of mast cell induction by long-term culture of mouse spleen cells without using exogenous mast cell growth factor (Z.-Q. Hu, T. Yoshida, and T. Shimamura, J. Immunol. Methods 149:173, 1992). Supernatants recovered from the long-term cultures contain endogenous interleukin 3 and soluble stem cell factor. These were assessed by the capacity of the recovered supernatants to foster the growth of a mast cell growth factor-dependent cell line and by neutralizing antibodies. Besides the soluble factors, cell-to-cell contacts mediated by membrane stem cell factor on splenic stromal cells and c-Kit receptors on mast cells also affect mast cell induction. Different lots of fetal calf serum (FCS) were examined to determine a possible trigger for cytokine production. FCS can be divided into mast cell-inducible and noninducible sera by this process. However, not all FCS lots contain mast cell growth factor. The mast cell-inducible lots contain lipopolysaccharide (LPS) confirmed by a Limulus assay. Polymyxin B can neutralize the mast cell induction activity. Non-mast cell-inducible FCS can be converted to inducible FCS by adding exogenous LPS. The results indicate that LPS as a trigger of cytokine production is responsible for mast cell induction.

Full text

PDF
3844

Images in this article

3846Image
on p.3846

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adachi S., Ebi Y., Nishikawa S., Hayashi S., Yamazaki M., Kasugai T., Yamamura T., Nomura S., Kitamura Y. Necessity of extracellular domain of W (c-kit) receptors for attachment of murine cultured mast cells to fibroblasts. Blood. 1992 Feb 1;79(3):650–656. [PubMed] [Google Scholar]
  2. Ansell J. D., Bancroft G. J. The biology of the SCID mutation. Immunol Today. 1989 Oct;10(10):322–325. doi: 10.1016/0167-5699(89)90181-3. [DOI] [PubMed] [Google Scholar]
  3. Broxmeyer H. E., Cooper S., Lu L., Hangoc G., Anderson D., Cosman D., Lyman S. D., Williams D. E. Effect of murine mast cell growth factor (c-kit proto-oncogene ligand) on colony formation by human marrow hematopoietic progenitor cells. Blood. 1991 May 15;77(10):2142–2149. [PubMed] [Google Scholar]
  4. Cavaillon J. M., Fitting C., David B. Presence of interleukin 3-like activity in the supernatants of lipopolysaccharide-stimulated mouse splenocytes. Biochem Biophys Res Commun. 1986 Aug 14;138(3):1322–1327. doi: 10.1016/s0006-291x(86)80427-2. [DOI] [PubMed] [Google Scholar]
  5. Cavaillon J. M., Vidard L., Boudaly S., Fitting C., Cohen L., Seman M., David B. Induction of interleukin-3 by interleukin-1 in the absence of other exogenous stimuli. Cell Immunol. 1990 Aug;129(1):176–188. doi: 10.1016/0008-8749(90)90196-x. [DOI] [PubMed] [Google Scholar]
  6. Clark-Lewis I., Schrader J. W., Wu Y. Y., Harris A. W. A B lymphoma cell line produces growth factors for hemopoietic, lymphoid, and mast cells. Cell Immunol. 1982 May 1;69(1):196–200. doi: 10.1016/0008-8749(82)90064-8. [DOI] [PubMed] [Google Scholar]
  7. Denburg J. A. Basophil and mast cell lineages in vitro and in vivo. Blood. 1992 Feb 15;79(4):846–860. [PubMed] [Google Scholar]
  8. Flanagan J. G., Chan D. C., Leder P. Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell. 1991 Mar 8;64(5):1025–1035. doi: 10.1016/0092-8674(91)90326-t. [DOI] [PubMed] [Google Scholar]
  9. Flanagan J. G., Leder P. The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell. 1990 Oct 5;63(1):185–194. doi: 10.1016/0092-8674(90)90299-t. [DOI] [PubMed] [Google Scholar]
  10. Fukushima N., Nishina H., Koishihara Y., Ohkawa H. Enhanced hematopoiesis in vivo and in vitro by splenic stromal cells derived from the mouse with recombinant granulocyte colony-stimulating factor. Blood. 1992 Oct 15;80(8):1914–1922. [PubMed] [Google Scholar]
  11. Galli S. J. New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest. 1990 Jan;62(1):5–33. [PubMed] [Google Scholar]
  12. Gilbert H. S., Ornstein L. Basophil counting with a new staining method using alcian blue. Blood. 1975 Aug;46(2):279–286. [PubMed] [Google Scholar]
  13. Hu Z. Q., Yoshida T., Shimamura T. Induction and identification of mast cells from long-term culture of mouse spleen cells without conditioned medium. J Immunol Methods. 1992 May 18;149(2):173–181. doi: 10.1016/0022-1759(92)90248-r. [DOI] [PubMed] [Google Scholar]
  14. Huang E., Nocka K., Beier D. R., Chu T. Y., Buck J., Lahm H. W., Wellner D., Leder P., Besmer P. The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell. 1990 Oct 5;63(1):225–233. doi: 10.1016/0092-8674(90)90303-v. [DOI] [PubMed] [Google Scholar]
  15. Hültner L., Druez C., Moeller J., Uyttenhove C., Schmitt E., Rüde E., Dörmer P., Van Snick J. Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9). Eur J Immunol. 1990 Jun;20(6):1413–1416. doi: 10.1002/eji.1830200632. [DOI] [PubMed] [Google Scholar]
  16. Ihle J. N., Keller J., Oroszlan S., Henderson L. E., Copeland T. D., Fitch F., Prystowsky M. B., Goldwasser E., Schrader J. W., Palaszynski E. Biologic properties of homogeneous interleukin 3. I. Demonstration of WEHI-3 growth factor activity, mast cell growth factor activity, p cell-stimulating factor activity, colony-stimulating factor activity, and histamine-producing cell-stimulating factor activity. J Immunol. 1983 Jul;131(1):282–287. [PubMed] [Google Scholar]
  17. Koyasu S., Nakauchi H., Kitamura K., Yonehara S., Okumura K., Tada T., Yahara I. Production of interleukin 3 and gamma-interferon by an antigen-specific mouse suppressor T cell clone. J Immunol. 1985 May;134(5):3130–3136. [PubMed] [Google Scholar]
  18. Levi-Schaffer F., Austen K. F., Caulfield J. P., Hein A., Bloes W. F., Stevens R. L. Fibroblasts maintain the phenotype and viability of the rat heparin-containing mast cell in vitro. J Immunol. 1985 Nov;135(5):3454–3462. [PubMed] [Google Scholar]
  19. Levi-Schaffer F., Austen K. F., Gravallese P. M., Stevens R. L. Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc Natl Acad Sci U S A. 1986 Sep;83(17):6485–6488. doi: 10.1073/pnas.83.17.6485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mosmann T. R., Bond M. W., Coffman R. L., Ohara J., Paul W. E. T-cell and mast cell lines respond to B-cell stimulatory factor 1. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5654–5658. doi: 10.1073/pnas.83.15.5654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nabel G., Galli S. J., Dvorak A. M., Dvorak H. F., Cantor H. Inducer T lymphocytes synthesize a factor that stimulates proliferation of cloned mast cells. Nature. 1981 May 28;291(5813):332–334. doi: 10.1038/291332a0. [DOI] [PubMed] [Google Scholar]
  22. Nakano T., Sonoda T., Hayashi C., Yamatodani A., Kanayama Y., Yamamura T., Asai H., Yonezawa T., Kitamura Y., Galli S. J. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med. 1985 Sep 1;162(3):1025–1043. doi: 10.1084/jem.162.3.1025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nishikawa M., Ozawa K., Tojo A., Yoshikubo T., Okano A., Tani K., Ikebuchi K., Nakauchi H., Asano S. Changes in hematopoiesis-supporting ability of C3H10T1/2 mouse embryo fibroblasts during differentiation. Blood. 1993 Mar 1;81(5):1184–1192. [PubMed] [Google Scholar]
  24. Plaut M., Pierce J. H., Watson C. J., Hanley-Hyde J., Nordan R. P., Paul W. E. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature. 1989 May 4;339(6219):64–67. doi: 10.1038/339064a0. [DOI] [PubMed] [Google Scholar]
  25. Razin E., Ihle J. N., Seldin D., Mencia-Huerta J. M., Katz H. R., LeBlanc P. A., Hein A., Caulfield J. P., Austen K. F., Stevens R. L. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol. 1984 Mar;132(3):1479–1486. [PubMed] [Google Scholar]
  26. Razin E., Rifkind A. B., Cordon-Cardo C., Good R. A. Selective growth of a population of human basophil cells in vitro. Proc Natl Acad Sci U S A. 1981 Sep;78(9):5793–5796. doi: 10.1073/pnas.78.9.5793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Schrader J. W. In in vitro production and cloning of the P cell, a bone marrow-derived null cell that expresses H-2 and Ia-antigens, has mast cell-like granules, and is regulated by a factor released by activated T cells. J Immunol. 1981 Feb;126(2):452–458. [PubMed] [Google Scholar]
  28. Smith C. A., Rennick D. M. Characterization of a murine lymphokine distinct from interleukin 2 and interleukin 3 (IL-3) possessing a T-cell growth factor activity and a mast-cell growth factor activity that synergizes with IL-3. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1857–1861. doi: 10.1073/pnas.83.6.1857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Suda T., Suda J., Spicer S. S., Ogawa M. Proliferation and differentiation in culture of mast cell progenitors derived from mast cell-deficient mice of genotype W/Wv. J Cell Physiol. 1985 Feb;122(2):187–192. doi: 10.1002/jcp.1041220204. [DOI] [PubMed] [Google Scholar]
  30. Tertian G., Yung Y. P., Guy-Grand D., Moore M. A. Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique. J Immunol. 1981 Aug;127(2):788–794. [PubMed] [Google Scholar]
  31. Thompson-Snipes L., Dhar V., Bond M. W., Mosmann T. R., Moore K. W., Rennick D. M. Interleukin 10: a novel stimulatory factor for mast cells and their progenitors. J Exp Med. 1991 Feb 1;173(2):507–510. doi: 10.1084/jem.173.2.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Williams D. E., Eisenman J., Baird A., Rauch C., Van Ness K., March C. J., Park L. S., Martin U., Mochizuki D. Y., Boswell H. S. Identification of a ligand for the c-kit proto-oncogene. Cell. 1990 Oct 5;63(1):167–174. doi: 10.1016/0092-8674(90)90297-r. [DOI] [PubMed] [Google Scholar]
  33. Williams D. E., Lyman S. D. Characterization of the gene-product of the Steel locus. Prog Growth Factor Res. 1991;3(4):235–242. doi: 10.1016/0955-2235(91)90002-l. [DOI] [PubMed] [Google Scholar]
  34. Zsebo K. M., Williams D. A., Geissler E. N., Broudy V. C., Martin F. H., Atkins H. L., Hsu R. Y., Birkett N. C., Okino K. H., Murdock D. C. Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell. 1990 Oct 5;63(1):213–224. doi: 10.1016/0092-8674(90)90302-u. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES